Azacitidine Injection shortage
Current 9 presentations · 9 manufacturers · first FDA posting Dec 18, 2020 · last update Oct 15, 2026
Manufacturers: Accord Healthcare Inc., Armas Pharmaceuticals Inc, Bristol Myers Squibb Co., Dr. Reddy's Laboratories, Inc., Eugia US LLC, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals USA, Inc., Meitheal Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Demand increase for the drug; Discontinuation of the manufacture of the drug; Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Azacitidine, Injection, 100 mg (NDC 16729-306-10) | Accord Healthcare Inc. | Current Available |
— | Posted Dec 21, 2020 Updated Oct 3, 2026 | |
| Azacitidine, Injection, 100 mg (NDC 72485-201-01) | Armas Pharmaceuticals Inc | Current Limited Availability |
Other | Estimated recovery: TBD | Posted Dec 18, 2020 Updated Jun 8, 2026 |
| Vidaza, Injection, 100 mg (NDC 59572-102-01) | Bristol Myers Squibb Co. | Current Available |
— | Posted Dec 18, 2020 Updated Oct 15, 2026 | |
| Azacitidine, Injection, 100 mg (NDC 43598-305-62) | Dr. Reddy's Laboratories, Inc. | Current Available |
— | Available to existing customers | Posted Dec 18, 2020 Updated Sep 29, 2026 |
| Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01) | Eugia US LLC | Current Unavailable |
Demand increase for the drug | On backorder. Recovery: TBD. Check wholesalers for inventory | Posted Dec 22, 2020 Updated Oct 2, 2026 |
| Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39) | Fresenius Kabi USA, LLC | Current Unavailable |
Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug | Posted Dec 18, 2020 Updated Oct 15, 2026 |
| Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | Posted Dec 18, 2020 Updated Sep 18, 2026 |
| Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30) | Meitheal Pharmaceuticals, Inc. | Current Available |
— | Posted Dec 18, 2020 Updated Aug 27, 2026 | |
| Azacitidine, Injection, 100 mg (NDC 68001-313-56) | Teva Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Estimated recovery: TBD | Posted Dec 22, 2020 Updated Oct 15, 2026 |